Medigene AG (OTCPK:MDGEF)
$ 2.59 0 (0%) Market Cap: 24.57 Mil Enterprise Value: 12.33 Mil PE Ratio: 0 PB Ratio: 1.12 GF Score: 53/100

Q2 2021 Medigene AG Earnings Call Transcript

Aug 12, 2021 / 01:00PM GMT
Release Date Price: $8.18
Anna Niedl
Medigene AG - VP, IR & Corporate Communications

Good afternoon and good morning to the US. My name is Anna Niedl. I'm responsible for Investor Relations at Medigene. I would like to welcome everybody also from my side to today's conference call in which we will describe Medigene's financial and operational results in the first half year of 2021.

Today's presentation is available for download on our website and this call will be recorded and will be accessible later on our website as well.

With us today on this conference call are Dolores Schendel, our Chief Executive and Chief Scientific Officer at Medigene; and Axel Malkomes, our Chief Financial and Chief Business Officer.

I would draw your attention to slide 2 and would like to remind you that as usual, during this conference call, we will present and discuss certain forward-looking statements. Please have a look at slide 2. And with that, I would like now to hand over to Axel Malkomes.

Axel Malkomes
Medigene AG - CFO & Chief Business Development Officer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot